LRRK2 and Parkinson disease: In relation to our knowledge of phosphatases of LRRK2, α-syn, and tau and the pathogenic nature of phosphorylations in these proteins, a strategy to target phosphatases in a way that will counteract PD-associated phosphorylation can be proposed.